{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:11:29Z","timestamp":1772104289113,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,2]]},"DOI":"10.7759\/cureus.93685","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:44:11Z","timestamp":1759391051000},"source":"Crossref","is-referenced-by-count":1,"title":["Complement-Mediated Thrombotic Microangiopathies With Predominant Renal Involvement in a Patient With Lupus Nephritis"],"prefix":"10.7759","author":[{"given":"Aikya","family":"Manchikalapati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Zinser Peniche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta C","family":"Machin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2019.1702057","article-title":"Renal microvascular lesions in lupus nephritis","volume":"42","author":"Ding Y","year":"2020","unstructured":"Ding Y, Tan Y, Qu Z, Yu F. Renal microvascular lesions in lupus nephritis. Ren Fail. 2020, 42:19-29. 10.1080\/0886022X.2019.1702057","journal-title":"Ren Fail"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0727-y","article-title":"Differential diagnosis of thrombotic microangiopathy in nephrology","volume":"18","author":"Sakari Jokiranta T","year":"2017","unstructured":"Sakari Jokiranta T, Viklicky O, Al Shorafa S, et al.. Differential diagnosis of thrombotic microangiopathy in nephrology. BMC Nephrol. 2017, 18:324. 10.1186\/s12882-017-0727-y","journal-title":"BMC Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma LM","year":"2021","unstructured":"Palma LM, Sridharan M, Sethi S. Complement in secondary thrombotic microangiopathy. Kidney Int Rep. 2021, 6:11-23. 10.1016\/j.ekir.2020.10.009","journal-title":"Kidney Int Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018019596","article-title":"Complement-mediated thrombotic microangiopathy associated with lupus nephritis","volume":"2","author":"Park MH","year":"2018","unstructured":"Park MH, Caselman N, Ulmer S, Weitz IC. Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv. 2018, 2:2090-4. 10.1182\/bloodadvances.2018019596","journal-title":"Blood Adv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-117723","article-title":"Clinical associations, treatment, and outcomes of renal-limited thrombotic microangiopathy","volume":"132","author":"Bouali E","year":"2018","unstructured":"Bouali E, Seitz-Polski B, Zanditenas D, et al.. Clinical associations, treatment, and outcomes of renal-limited thrombotic microangiopathy. Blood. 2018, 132:4978. 10.1182\/blood-2018-99-117723","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100690","article-title":"Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy","volume":"38","author":"van Doorn DP","year":"2025","unstructured":"van Doorn DP, Tobal R, Abdul-Hamid MA, van Paassen P, Timmermans SA. Etiology and outcomes of kidney-limited and systemic thrombotic microangiopathy. Mod Pathol. 2025, 38:100690. 10.1016\/j.modpat.2024.100690","journal-title":"Mod Pathol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/ar4142","article-title":"The spectrum of renal thrombotic microangiopathy in lupus nephritis","volume":"15","author":"Song D","year":"2013","unstructured":"Song D, Wu LH, Wang FM, et al.. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013, 15:R12. 10.1186\/ar4142","journal-title":"Arthritis Res Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.23662","article-title":"Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis","volume":"58","author":"Cohen D","year":"2008","unstructured":"Cohen D, Koopmans M, Kremer Hovinga IC, et al.. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008, 58:2460-9. 10.1002\/art.23662","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0961203310368409","article-title":"Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases","volume":"19","author":"Shen Y","year":"2010","unstructured":"Shen Y, Chen XW, Sun CY, Dai M, Yan YC, Yang CD. Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases. Lupus. 2010, 19:1195-203. 10.1177\/0961203310368409","journal-title":"Lupus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811504","article-title":"Complement-mediated endothelial damage in thrombotic microangiopathies","volume":"9","author":"Blasco M","year":"2022","unstructured":"Blasco M, Guill\u00e9n-Olmos E, Diaz-Ricart M, Palomo M. Complement-mediated endothelial damage in thrombotic microangiopathies. Front Med (Lausanne). 2022, 9:811504. 10.3389\/fmed.2022.811504","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre CM","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, et al.. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013, 368:2169-81. 10.1056\/NEJMoa1208981","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/382877-complement-mediated-thrombotic-microangiopathies-with-predominant-renal-involvement-in-a-patient-with-lupus-nephritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T07:44:13Z","timestamp":1759391053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/382877-complement-mediated-thrombotic-microangiopathies-with-predominant-renal-involvement-in-a-patient-with-lupus-nephritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.93685","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,2]]}}}